Publication | Open Access

The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity

ObesityMetabolic SyndromeMetabolic DisorderMedicinePhysiologyDiabetesHypothalamic PeptideMetabolic RegulationMetabolismPostmenopausal ObesityEndocrinologyPharmacologyRelated Metabolic AbnormalitiesMouse ModelGastrointestinal Peptide HormoneHealth Sciences